-
Oncogenic Kras initiates leukemia in hematopoietic stem cells.
Sabnis AJ, Cheung LS, Dail M, Kang HC, Santaguida M, Hermiston ML, Passegué E, Shannon K, Braun BS.
PLoS Biol. 2009 Mar 17; 7(3):e59.
[PLoS Biol. 2009]
-
Suppression of E-protein activity interferes with the development of BCR-ABL-mediated myeloproliferative disease.
Ko J, Patel N, Ikawa T, Kawamoto H, Frank O, Rivera RR, Van Etten RA, Murre C.
Proc Natl Acad Sci U S A. 2008 Sep 2; 105(35):12967-72. Epub 2008 Aug 25.
[Proc Natl Acad Sci U S A. 2008]
-
Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth.
Sayyah J, Magis A, Ostrov DA, Allan RW, Braylan RC, Sayeski PP.
Mol Cancer Ther. 2008 Aug; 7(8):2308-18.
[Mol Cancer Ther. 2008]
- » See all...